LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | CGP60474 | 0.37 | uM | LJP5 | 3 | F04 | 72 | hr | 1209 | 612 | 4093 | 0.1495 | -0.2072 |
MDA-MB-231 | NU7441 | 10.0 | uM | LJP5 | 3 | C07 | 72 | hr | 1235 | 1159 | 4513 | 0.2568 | -0.0235 |
MDA-MB-231 | Dactolisib | 10.0 | uM | LJP5 | 3 | M13 | 72 | hr | 1235 | 1716 | 4513 | 0.3802 | 0.1465 |
Hs 578T | XL147 | 10.0 | uM | LJP5 | 3 | G07 | 72 | hr | 658 | 3038 | 3846 | 0.7899 | 0.7465 |
MDA-MB-231 | Palbociclib | 10.0 | uM | LJP6 | 3 | E13 | 72 | hr | 1235 | 1696 | 4513 | 0.3758 | 0.1404 |
MDA-MB-231 | PF562271 | 10.0 | uM | LJP6 | 3 | F13 | 72 | hr | 1235 | 501 | 4513 | 0.1110 | -0.2242 |
MDA-MB-231 | PD184352 | 10.0 | uM | LJP5 | 3 | L07 | 72 | hr | 1235 | 1600 | 4513 | 0.3545 | 0.1111 |
MDA-MB-231 | PD0325901 | 10.0 | uM | LJP6 | 3 | E01 | 72 | hr | 1235 | 1030 | 4513 | 0.2282 | -0.0628 |
MCF7 | CGP60474 | 0.37 | uM | LJP6 | 3 | G04 | 72 | hr | 1209 | 766 | 4093 | 0.1872 | -0.1538 |
MCF7 | CP724714 | 0.37 | uM | LJP5 | 3 | A10 | 72 | hr | 1209 | 3788 | 4093 | 0.9255 | 0.8942 |
MDA-MB-231 | PD173074 | 10.0 | uM | LJP6 | 3 | I07 | 72 | hr | 1235 | 1710 | 4513 | 0.3789 | 0.1446 |
BT-20 | GSK 690693 | 0.12 | uM | LJP5 | 3 | F23 | 72 | hr | 1097 | 2899 | 3769 | 0.7691 | 0.6742 |
MCF7 | CHIR-99021 | 0.37 | uM | LJP6 | 3 | P16 | 72 | hr | 1209 | 3690 | 4093 | 0.9015 | 0.8602 |
MDA-MB-231 | PF431396 | 10.0 | uM | LJP5 | 3 | E07 | 72 | hr | 1235 | 435 | 4513 | 0.0964 | -0.2444 |
MCF7 | Crizotinib | 0.37 | uM | LJP5 | 3 | A22 | 72 | hr | 1209 | 3246 | 4093 | 0.7931 | 0.7063 |
BT-20 | PHA-793887 | 0.04 | uM | LJP6 | 3 | E24 | 72 | hr | 1097 | 2643 | 3769 | 0.7012 | 0.5784 |
MDA-MB-231 | Pelitinib | 10.0 | uM | LJP5 | 3 | I13 | 72 | hr | 1235 | 748 | 4513 | 0.1657 | -0.1489 |
MDA-MB-231 | PF477736 | 10.0 | uM | LJP5 | 3 | J19 | 72 | hr | 1235 | 921 | 4513 | 0.2041 | -0.0961 |
MCF7 | CP466722 | 0.37 | uM | LJP5 | 3 | I10 | 72 | hr | 1209 | 4211 | 4093 | 1.0288 | 1.0409 |
BT-20 | WZ3105 | 0.37 | uM | LJP5 | 3 | D22 | 72 | hr | 1097 | 1209 | 3769 | 0.3207 | 0.0418 |